Laura Dominguez-Monino

Badajoz, EX, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Atezolizumab plus platinum-based chemotherapy and etoposide as first-line treatment for metastatic small cell lung cancer: A retrospective multicenter observational study.

Atezolizumab plus platinum-based chemotherapy and etoposide as first-line treatment for metastatic small cell lung cancer: A retrospective multicenter observational study.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: July 28, 2025

Atezolizumab plus platinum-based chemotherapy and etoposide as first-line treatment for metastatic small cell lung cancer: a retrospective multicenter observational study.

Atezolizumab plus platinum-based chemotherapy and etoposide as first-line treatment for metastatic small cell lung cancer: a retrospective multicenter observational study.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: July 28, 2025

Vedolizumab trough concentrations and clinical outcomes in patients with Crohn's disease: a real-world observational study comparing intravenous and subcutaneous administration.

Vedolizumab trough concentrations and clinical outcomes in patients with Crohn's disease: a real-world observational study comparing intravenous and subcutaneous administration.

Journal: European journal of hospital pharmacy : science and practice

Published: May 28, 2025

Usefulness of therapeutic drug monitoring of vedolizumab in the control of response in Crohn's disease.

Usefulness of therapeutic drug monitoring of vedolizumab in the control of response in Crohn's disease.

Journal: Medicina clinica

Published: May 01, 2025

[Translated article] Acute esophageal necrosis in a patient with lung cancer under treatment with osimertinib: Case report.

[Translated article] Acute esophageal necrosis in a patient with lung cancer under treatment with osimertinib: Case report.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: April 03, 2025

Acute esophageal necrosis in a patient with lung cancer under treatment with osimertinib: Case report.

Acute esophageal necrosis in a patient with lung cancer under treatment with osimertinib: Case report.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: April 03, 2025

[Translated article] Influence of age on the efficacy of immunochemotherapy in non-small cell lung cancer.

[Translated article] Influence of age on the efficacy of immunochemotherapy in non-small cell lung cancer.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: December 09, 2024

[Translated article] Therapeutic drug monitoring of dalbavancin: A systematic review of strategies and clinical applications in the treatment of complex infections.

[Translated article] Therapeutic drug monitoring of dalbavancin: A systematic review of strategies and clinical applications in the treatment of complex infections.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: December 04, 2024

Showing 1-8 of 8

Last Updated: 09/26/2026